Effects of cancer on platelets.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Seminars in Oncology

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.seminoncol.2014.04.015PMID 25023347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis

  2014cited by this paper
• Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.

  2014cited by this paper
• Platelets in cancer and thrombosis

  2014cited by this paper
• Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.

  2014cited by this paper
• A novel and essential role for FcγRIIa in cancer cell-induced platelet activation.

  2014cited by this paper
• Thrombocytosis has a negative prognostic value in lung cancer.

  2013cited by this paper
• Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

  2013cited by this paper
• Epidemiology of cancer-associated venous thrombosis.

  2013cited by this paper
• Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer

  2013cited by this paper
• Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.

  2013cited by this paper
• Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

  2013cited by this paper
• Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

  2012cited by this paper
• Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer.

  2012cited by this paper
• The relationship between tissue factor and cancer progression: insights from bench and bedside.

  2012cited by this paper
• Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer.

  2012cited by this paper
• Platelet receptors.

  2012cited by this paper
• Paraneoplastic thrombocytosis in ovarian cancer.

  2012cited by this paper
• Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

  2012cited by this paper
• Classification, Functions, and Clinical Relevance of Extracellular Vesicles

  2012cited by this paper
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• Contribution of platelets to tumour metastasis

  2011cited by this paper
• Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer.

  2011cited by this paper
• Arterial thrombosis in ambulatory cancer patients treated with chemotherapy.

  2011cited by this paper
• Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes.

  2011cited by this paper
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

  2011cited by this paper
• Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

  2010cited by this paper
• Systemic inflammation as a confounding factor in cancer biomarker discovery and validation

  2010cited by this paper
• Extracellular DNA traps promote thrombosis

  2010cited by this paper
• High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

  2010cited by this paper
• Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

  2009cited by this paper
• Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

  2009cited by this paper
• Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo

  2009cited by this paper
• Venous thromboembolism prophylaxis and treatment in patients with cancer.

  2008cited by this paper
• Development and validation of a predictive model for chemotherapy-associated thrombosis.

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.

  2007cited by this paper
• High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

  2007cited by this paper
• Clinical Significance of Platelet Count in Patients with Renal Cell Carcinoma

  2007cited by this paper
• Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

  2007cited by this paper
• Platelet Aggregation-Induced by Caco-2 Cells: Regulation by Matrix Metalloproteinase-2 and Adenosine Diphosphate

  2006cited by this paper
• The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.

  2006cited by this paper
• Lineage-specific hematopoietic growth factors.

  2006cited by this paper
• Lineage-specific hematopoietic growth factors.

  2006cited by this paper
• Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines

  2005cited by this paper
• Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine

  2005cited by this paper
• Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

  2005cited by this paper
• Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study

  2005cited by this paper
• Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas.

  2005cited by this paper
• Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.

  2004cited by this paper
• Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

  2004cited by this paper
• Neutrophil Extracellular Traps Kill Bacteria

  2004cited by this paper
• Impact of pretreatment thrombocytosis on survival in primary breast cancer

  2003cited by this paper
• Thrombopoietin-producing hepatocellular carcinoma.

  2003cited by this paper
• Platelets and cancer.

  2002cited by this paper
• Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.

  2001cited by this paper
• Production of thrombopoietin by human carcinomas and its novel isoforms.

  1999cited by this paper
• Thrombopoietin.

  1998cited by this paper
• Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.

  1995cited by this paper
• In vitro interactions between human breast cancer cells MCF-7 and human blood platelets.

  1987cited by this paper
• Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.

  1982cited by this paper
• The structure and growth of valve-pocket thrombi in femoral veins

  1974cited by this paper
• Antimetastatic effects associated with platelet reduction.

  1968cited by this paper
• THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE.

  1964cited by this paper

• Platelet FcRγ inhibits tumor metastasis by preventing the colonization of circulating tumor cells.

  2025cites this paper
• Chemotherapy and hemostasis disorders

  2025cites this paper
• Soluble B7 and TNF family in colorectal cancer: Serum level, prognostic and treatment value.

  2025cites this paper
• Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation

  2024cites this paper
• Acute coronary syndrome in patients with oncological diseases

  2024cites this paper
• Tumor-educated platelets.

  2023cites this paper
• Galectin functions in cancer-associated inflammation and thrombosis

  2023cites this paper
• Neutrophil extracellular traps-associated markers in malignant neoplasms of the female reproductive system after surgical treatment and adjuvant chemotherapy

  2023cites this paper
• Platelet‑derived microvesicles (PMVs) in cancer progression and clinical applications

  2022cites this paper
• Platelet-derived microvesicles (PMVs) in cancer progression and clinical applications

  2022cites this paper
• Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer

  2022cites this paper
• Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes

  2022cites this paper
• Uptake of platelets by cancer cells and recycling of the platelet protein CD42a

  2021cites this paper
• High pretreatment platelet-to-lymphocyte ratio is related to poor prognosis in the squamous cell carcinoma of the larynx and hypopharynx in male patients

  2021cites this paper
• The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon

  2021cites this paper
• Arterial Thrombosis in Cancer Patients: An Update

  2021cites this paper
• Cardiac metastasis causes paradoxical malignant embolism

  2021cites this paper
• Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer

  2021cites this paper
• Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection

  2021cites this paper
• Platelets in aging and cancer—“double-edged sword”

  2020cites this paper
• Spontaneous arterial thrombosis in a patient with advanced ovarian clear cell cancer: a case report and literature review

  2020cites this paper
• Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis

  2020cites this paper
• The Role of Platelets in Tumor Growth, Metastasis, and Immune Evasion

  2019cites this paper
• Thrombin Generation and Cancer: Contributors and Consequences

  2019cites this paper
• Influence of Resveratrol on the Immune Response

  2019cites this paper
• Neutrophil extracellular traps induced by activated platelets contribute to procoagulant activity in patients with colorectal cancer.

  2019cites this paper
• Soluble levels of sCD40L and s4‐1BB are associated with a poor prognosis in elderly patients with colorectal cancer

  2019cites this paper
• Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia

  2018cites this paper
• Exosomes play roles in sequential processes of tumor metastasis

  2018cites this paper
• Arterial thrombosis and cancer.

  2018cites this paper
• Platelets contribute to the initiation of colitis‐associated cancer by promoting immunosuppression

  2018cites this paper
• Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patients with non-small cell lung cancer and predicting Tumor-Node-Metastasis stages.

  2018cites this paper
• Survival Mechanisms and Influence Factors of Circulating Tumor Cells

  2018cites this paper
• Platelet “first responders” in wound response, cancer, and metastasis

  2017cites this paper
• The prognostic value of D-dimer levels in endometrial cancer patients treated with intensity-modulated radiation therapy

  2017cites this paper
• Platelet-derived Extracellular Vesicles: An Emerging Therapeutic Approach

  2017cites this paper
• The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis

  2017cites this paper
• Thrombin generation - a potentially useful biomarker of thrombotic risk in Philadelphia-negative myeloproliferative neoplasms.

  2017cites this paper
• Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA

  2017cites this paper
• Platelets: “First Responders” in Cancer Progression and Metastasis

  2017cites this paper
• Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor Progression

  2016cites this paper
• がんの転移治療の新たなターゲット：がん細胞―血小板相互作用

  2016cites this paper
• Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer

  2016cites this paper
• The prothrombotic activity of cancer cells in the circulation.

  2016cites this paper
• Prognostic role of the combination of platelet count and neutrophil–lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma

  2016cites this paper
• Platelets — Allies of Tumour Cells

  2015cites this paper
• Information transfer by exosomes: A new frontier in hematologic malignancies.

  2015cites this paper
• Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment

  2015cites this paper
• Inhibition of the interactions between metastatic human breast cancer cells and platelets by β-nitrostyrene derivatives.

  2015cites this paper
• Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).

  2015cites this paper
• Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation

  2015cites this paper
• Venous thrombosis and cancer: from mouse models to clinical trials

  2015cites this paper
• Migration of Myeloid-derived Suppressor Cells to Tumor and Tumor-Draining Lymph Node in a Murine Model of Breast Cancer

  2015cites this paper